Biogen Inc. closed 41.04% below its 52-week high of $238.00, which the company achieved on July 12th.

Biogen enhances its portfolio and margins amidst market challenges and competition. Click here to find out why BIIB stock is ...

Cambridge-based biotechnology company Biogen Inc. announced Monday that it will move its global headquarters to a new ...

When Biogen acquired Nightstar Therapeutics in 2019, it added a pair inherited retinal disorder (IRD) gene therapies that it hoped would accelerate a push into the fast-evolving category.

Biogen has ducked out of a four-year-old collaboration with Karyopharm on a drug candidate for the neurodegenerative disease amyotrophic lateral sclerosis that could have been worth up to $217 ...

Investors with a lot of money to spend have taken a bullish stance on Biogen (NASDAQ:BIIB). And retail traders should know. We noticed this today when the trades showed up on publicly available ...

In a report released yesterday, William Pickering from Bernstein maintained a Hold rating on Biogen (BIIB – Research Report), with a price target of $159.00. The company’s shares closed ...

For decades, Biogen has built a legacy in neuroscience — having brought to market drugs that have changed lives for multiple sclerosis, Alzheimer’s disease, spinal muscular atrophy ...

Back when innerspring mattresses ruled the market, using box springs was a no-brainer. The flexible, spring-filled mattress bases allowed for flexible support while lifting the mattress to a then ...

Meta’s Messenger has a new logo set in Facebook blue. The instant messaging app dropped the multicolor gradient used in its previous logo for a solid blue that matches the shade used by Meta’s ...